The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Katasonov A.B.

Curcumin as an ajuvant treatment of depression: mechanisms of action and application prospects

Authors:

Katasonov A.B.

More about the authors

Views: 48571

Downloaded: 626


To cite this article:

Katasonov AB. Curcumin as an ajuvant treatment of depression: mechanisms of action and application prospects. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(2):125‑131. (In Russ.)
https://doi.org/10.17116/jnevro2020120021125

Recommended articles:
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Sleep diso­rders and onco­logical diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):125-131
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anti­depressants in psychiatric practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):126-132
Coro­nary microvascular dysfunction in rheumatic diseases — what do we know today?. Russian Journal of Preventive Medi­cine. 2024;(9):138-143

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.